What is the price target for BTLS stock?
9 analysts have analysed BTLS.BR and the average price target is 7.21 EUR. This implies a price increase of 329.05% is expected in the next year compared to the current price of 1.68.
BIOTALYS NV (BTLS.BR) Forecast, Price Target & Analyst Ratings
EBR:BTLS • BE0974386188
Current stock price
1.68 EUR
+0.02 (+1.2%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOTALYS NV (BTLS.BR).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€7.21
Upside
+ 329.05%
From current price of €1.68 to mean target of €7.21, Based on 9 analyst forecasts
Low
€5.15
Median
€7.24
High
€9.45
Price Target Revisions
1 Month
-10.17%
3 Months
-10.55%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for BTLS.BR. The average price target is 7.21 EUR. This implies a price increase of 329.05% is expected in the next year compared to the current price of 1.68.
The average price target has been revised downward by 10.55% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.44%
BTLS.BR was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about BTLS.BR.
In the previous month the buy percentage consensus was at a similar level.
BTLS.BR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 27, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 125.00% | N/A 24.69% | N/A | N/A | N/A | N/A | N/A | |||||||
| EBITDA YoY % growth | -8.65M | -12.24M -41.50% | -16.61M -35.70% | -20.956M -26.16% | -19.105M 8.83% | -11.664M 38.95% | N/A -19.80% | N/A 46.23% | N/A -61.09% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.24M | -13.28M -43.72% | -18.08M -36.14% | -22.531M -24.62% | -20.891M 7.28% | -13.492M 35.42% | N/A -11.89% | N/A 22.30% | N/A 2.90% | N/A | N/A -9.00% | N/A 56.88% | N/A 140.42% | N/A 626.47% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 2.44% | N/A 5.00% | N/A | N/A 1.76% | N/A 47.32% | N/A -57.62% | N/A | N/A | N/A | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
5.80%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
10.43%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
2.83%
EBIT Next 5 Year
N/A
BIOTALYS NV / BTLS.BR Forecast FAQ
Can you provide the upcoming earnings date for BIOTALYS NV?
BIOTALYS NV (BTLS.BR) will report earnings on 2026-03-27, after the market close.
Can you provide the analyst count for BIOTALYS NV stock?
The number of analysts covering BIOTALYS NV (BTLS.BR) is 9.